During the past trading week (July 1 to 5), Canadian marijuana producer Canopy Growth (NYSE:CGC,TSX:WEED) fired its co-founder and acting co-CEO.

Criticism from a marijuana executive to the Canadian regulators made headlines, while a rebalance for three marijuana exchange traded funds (ETFs) also caught attention.

Here’s a closer look at some of the biggest news during last week’s trading period.

Canopy Growth begins leadership change period

Canopy Growth, one of the world’s largest marijuana firms, announced on Wednesday (July 3) that it is undergoing a significant leadership change. It has decided to part ways with its co-founder and co-CEO Bruce Linton, who was terminated by the company.

“I think the board had decided they wanted a different chair and a different co-CEO,” Linton said during a televised interview. “So I’m out effective immediately and there’s a search to replace the transitioning co-CEO.”

During a conference call with analysts and investors, the management team of Canopy Growth’s biggest investor, alcohol producer Constellation Brands (NYSE:STZ), expressed disapproval of some of the recent financial results from the marijuana producer.

“While we remain happy with our investment in the cannabis space and its long-term potential, we were not pleased with Canopy’s recent reported year-end results,” Bill Newlands, CEO of Constellation Brands, said.

“However, we continue to aggressively support Canopy on a more focused, long-term strategy to win markets and form factors that matter while paving a clear path to profitability.”

Linton gained notoriety as the leader of Canopy and a leading voice in the Canadian cannabis market. Canopy’s other co-CEO, Mark Zekulin, assumed sole possession as leading executive until the transition period is completed and a replacement is found.

“I personally remain committed to a successful transition over the coming year as we begin a process to identify new leadership that will drive our collective vision forward,” Zekulin said in a statement.

Ontario prepares for second round of marijuana retail lottery

Ontario announced that the second stage of its retail lottery will determine the license holder winners for the next 42 cannabis shops in the province. In addition to these new shops, the province will seek to open eight stores on First Nations reserves, which will be determined on a first come, first served basis.

On Wednesday, the Alcohol and Gaming Commission of Ontario (AGCO) informed stakeholders that applications of interest for the new lottery will begin sometime this summer.

Provincial ministers expressed frustration for continued supply issues from licensed cannabis producers.

“While the federal supply issues persist, we cannot in good conscience issue an unlimited number of licences to businesses,” said Ontario attorney general Doug Downey. “A phased-in approach remains necessary.”

Cannabis ETFs gets new stocks during quarterly rebalance

This past week, Horizons ETFs Management (Canada) announced its quarterly rebalance for three of its marijuana ETFs: the Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ), the Horizons US Marijuana Index ETF (NEO:HMUS) and the Horizons Emerging Marijuana Growers Index ETF (NEO:HMJR), adding 10, 11 and 20 stocks respectively.

Steve Hawkins, president and CEO of Horizons ETFs, said that, despite some of the growth HMMJ has seen throughout the year, the marijuana sector has taken a hit lately. “The last quarter was a difficult one for marijuana-sector investors. After more than a 50 (percent) runup in the value of HMMJ, performance in the sector tailed off,” he said.

The ETF executive said he expects to see an increase of firms focused on the US cannabidiol market, added to its funds moving forward.

Horizons ETFs issued an update on the performance of HMMJ, indicating as of the half-way mark of the trading year the ETF had seem a rise of 31 percent in value. As of Friday July 5, the ETF traded at a price of C$18.11, while balancing net assets worth C$834.2 million.

Marijuana exec puts federal government on notice for restrictions

In a wide-ranging interview with BNN-Bloomberg Mike Gorenstein, CEO of Cronos Group (NASDAQ:CRON,TSX:CRON), criticized the Canadian government for its restrictions on marijuana companies and that leading to fall off behind the emerging legal US market.

Gorenstein also threw cold water on the projections of the cannabis edibles and infused market due to the restrictions on marketing and a potential lack of understanding for the amount of demand this new market will warrant in Canada.

“We really think there needs to be some changes to the regulations or we’re not going to be happy with single-serve packaging,” the Cronos executive said.

In June, a group of marijuana stakeholders joined forces with the Canadian Chamber of Commerce to launch a new collective that will seek a voice representing the business interests of the industry, including policy making.

Market updates

On Tuesday (July 2), Canadian cannabis producer Aleafia Health (TSX:ALEF,OTCQX:ALEAF) confirmed that it would begin exporting medical cannabis products to its partner in Australia, after obtaining a clearing permit from Health Canada.

“We continue to prove the international viability of our highly differentiated cannabis health and wellness ecosystem with products, clinic operations, education and distribution,” Julian Fantino, Aleafia Health Chairman, said in the press release.

Aleafia Health’s owns a 10 percent stake in its Australian partner CannaPacific, which is a local licensed producer that will now be tasked with distributing the medical cannabis supply.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less